Element Biosciences Lands $15M to Develop New Genetic Analysis Tools
Xconomy
JUNE 19, 2019
Most of the genetic analysis done today is performed on machines made by Illumina, the DNA sequencing giant. Now a former director from the company is leading a startup that has raised $15 million to develop new genome sequencing tools. San Diego’s Element Biosciences said Tuesday that it had secured a Series A round led by Foresite Capital, a healthcare and life sciences venture capital firm based in San Francisco, and Silicon Valley’s Venrock.
Let's personalize your content